Name: iSpecimen Inc. (ISPC) Financial Statements
Creator: FinSpry

iSpecimen Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

iSpecimen Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	9.29	9.93	10.40	11.14	8.18
Cost of Revenue	5.30	4.82	4.76	5.25	3.59
Gross Profit	3.99	5.11	5.65	5.89	4.60
Operating Expenses
Research & Development	3.53	3.57	2.66	0.88	1.47
Selling, General & Administrative	12.65	11.68	12.37	9.40	5.54
Operating Expenses	16.72	16.28	15.83	9.40	7.01
Operating Income	-12.73	-11.17	-10.19	-5.93	-2.41
Other Income/Expense
Interest Income	0.04	0.34	0.17	0.01	0.00
Interest Expense	0.22	0.23	0.24	2.10	-2.10
Other Income/Expense	0.41	-0.04	0.01	0.95	-0.15
Income
Income Before Tax	-12.50	-11.10	-10.25	-4.14	-4.65
Income Tax Expense	0.00	0.21	0.00	0.00	0.00
Net Income	-12.50	-11.10	-10.25	-8.96	-4.65
Net Income - Continuous Operations	-12.50	-11.10	-10.25	-8.96	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-9.98	-8.75	-8.80	-2.98	-2.36
EBIT	-12.28	-10.87	-10.01	-4.86	-2.41
Depreciation & Amortization	2.29	2.12	1.21	0.05	0.04
Earnings Per Share
Basic EPS	-18.00	-25.00	-23.00	-42.00	-99.00
Diluted EPS	-18.00	-25.00	-23.00	-42.00	-99.00
Basic Shares Outstanding	0.71	0.45	0.44	0.21	0.05
Diluted Shares Outstanding	0.71	0.45	0.44	0.21	0.05